Table 1 Characterization of subjects
Healthy Controls | Asthmatics | P value | |
|---|---|---|---|
(N = 10) | (N = 10) | ||
Age yrs. (SD) | 10.3 (3.6) | 11.7 (3.4) | 0.4 |
Females (%) | 60% | 20% | 0.07 |
History of Eczema (yes; %) | 0 | 4 (40%) | N/A |
History of Allergic Rhinitis (yes; %) | 0 | 9 (90%) | N/A |
Positive RAST (yes; %) | 0 | 9 (90%) | N/A |
Use of inhaled steroids at enrollment (yes; %) | 0 | 9 (90%) | N/A |
IgE IU/mL (SD) | 21.3 (12.4) | 916 (1616) | 0.0005 |
FVC % predicted (SD) | 101 (13.2) | 100.7 (11.5) | 0.9 |
FEV1/FVC Ratio (SD) | 0.89 (0.04) | 0.83 (0.05) | 0.04 |
FEV1 % predicted (SD) | 99.8 (14.5) | 96.6 (12.1) | 0.6 |
FEF25–75 % predicted (SD) | 99 (20.4) | 88 (18.5) | 0.2 |
FENO ppb (SD) | 9.3 (4.6) | 14.9 (8.8) | 0.2 |